Vestis Reports Fourth Quarter and Full-Year 2025 Results and Announces Strategic Business Transformation ATLANTA, GA, December 1, 2025 – Vestis Corporation (NYSE: VSTS), a leading provider of uniforms and workplace supplies, today announced its results for the fiscal fourth quarter and full-year periods ended October 3, 2025, both of which reflect an additional week of operations when compared to the same prior year period. Fourth Quarter 2025 Results Management Commentary "We ended fiscal 2025 in a good po ...

Financial Results Announcement - NewtekOne, Inc. announced its financial results for the three and nine months ended September 30, 2025[7]. - The press release detailing the financial results was issued on October 29, 2025[7]. - The financial results are available on NewtekOne's investor relations website and the SEC's website[6]. Company Information - The company is registered under the Securities Exchange Act of 1934 and has various securities listed on the Nasdaq Global Market[3]. - The company operates from Boca Raton, Florida, and is incorporated in Maryland[2]. Forward-Looking Statements and Risks - NewtekOne's forward-looking statements are subject to significant risks and uncertainties, and actual results may differ materially[6]. - The report includes a note regarding forward-looking statements and risk factors associated with the company's operations[6]. Compliance and Reporting - The company has not elected to use the extended transition period for complying with new financial accounting standards[5]. - The report was signed by Barry Sloane, the Chief Executive Officer, President, and Chairman of the Board[13]. - The report does not include specific financial metrics or performance indicators[8].

Revenue and Financial Performance - The software business accounted for 58% of total revenue for the fiscal year ended August 31, 2025[33]. - The services business represented 42% of total revenue for the fiscal year ended August 31, 2025, an increase from 39% in 2023[47]. - Software revenue accounted for 58% of total revenue in fiscal year 2025, down from 61% in 2023[52]. - Revenue increased by $9.2 million, or 13%, to $79.2 million for the fiscal year ended August 31, 2025, compared to $70.0 million for the fiscal year ended August 31, 2024[206]. - Cost of revenues increased by $6.1 million, or 23%, primarily due to a $3.2 million or 49% increase in software-related costs and a $2.9 million or 14% increase in service-related costs[207]. - Gross profit increased by $3.1 million, or 7%, to $46.2 million, with gross margin percentages of 58% for 2025 and 62% for 2024, indicating a decline in gross margin[208]. - The company reported a net loss of $64.7 million for the fiscal year ended August 31, 2025, compared to a net income of $9.9 million for the fiscal year ended August 31, 2024, representing a decline of 750%[205]. - The company incurred $77.2 million in impairments for the fiscal year ended August 31, 2025, which significantly impacted overall financial performance[205]. - Other income decreased by $4.9 million, or 78%, to $1.4 million for the fiscal year ended August 31, 2025, compared to $6.3 million for the fiscal year ended August 31, 2024[205]. Product Development and Innovation - Version 13 of ADMET Predictor was released in June 2025, introducing new features including OBESITYsym™ and Thales™[35]. - GastroPlus version 10 (branded as GPX™) was released in May 2024, featuring a redesigned platform with advanced models and integrated ML technology[38]. - The ADMET Predictor software predicts over 175 different properties for molecular structures, enhancing drug discovery efficiency[33]. - The company has made significant investments in improving integration of its software models and enhancing its AI/ML engine[37]. - The company supports clients in drug development from early discovery through clinical trials to commercialization[23]. - The company aims to derive more revenues from existing clients by expanding their use of products and services[100]. Strategic Initiatives and Collaborations - The company has entered collaborations for validation of ADMET Predictor models and development of new AI drug discovery offerings[39]. - The company pivoted to an account-based solution selling business model during Q4 2025, focusing on client pain points across the drug development lifecycle[55]. - The company is actively seeking strategic acquisitions to expand its pharmaceutical software portfolio and services offerings[60]. - The company has developed products internally and intends to continue licensing or acquiring technology from third parties when it makes business sense[64]. Employee Engagement and Corporate Culture - The company employed 213 people as of August 31, 2025, with over 70% having backgrounds in life sciences software, services, and R&D[71]. - The voluntary turnover rate was under 6% in fiscal year 2024, indicating strong employee engagement[72]. - The company plans to place greater emphasis on leadership development and succession planning in the coming year[76]. - The company maintains a remote-first philosophy to support employee work-life balance[89]. - The company has a paid parental leave program and increased focus on physical and mental wellness for employees[92]. Risks and Challenges - The company faces risks from increasing competition and costs in the pharmaceutical and biotechnology industries[102]. - The life science market for modeling and simulation software is highly competitive, with significant pressure from larger technology companies and open-source alternatives[105]. - The lengthy sales cycle may lead to delays in recognizing revenue, negatively impacting financial results if contracts are not finalized[110]. - Fixed-price contracts pose financial risks, including potential losses from underpricing or overrunning cost estimates[111]. - The company faces risks associated with global operations, including currency fluctuations and political instability, which could adversely affect financial results[114]. - Changes in U.S. and international tax laws could negatively impact the company's effective tax rate and overall financial results[115]. - The company is dependent on key personnel, and the loss of these employees could harm business operations[122]. - Acquisitions and strategic alliances carry risks, including integration challenges and potential undiscovered liabilities[123]. - The company faces foreign currency exchange rate risks due to international operations, which could materially affect revenues and profit margins[126]. - The reliance on a single internal hosting facility and Amazon Web Services for operations poses risks; disruptions could adversely impact business[139]. Compliance and Governance - The company is committed to strong corporate governance practices, with a diverse Board of Directors overseeing risk management[94]. - The company emphasizes the importance of data security and compliance with various data privacy laws, including the EU GDPR and China's PIPL[92]. - The company has implemented a comprehensive data privacy management program to comply with evolving data privacy laws globally[138]. - Changes in data privacy laws could impose additional compliance costs and operational complexities for the company[136]. - The company has established a comprehensive cybersecurity program to address risks and ensure compliance with legal obligations, guided by industry best practices[174]. - As of the report date, there are no known cybersecurity incidents that have materially impacted the company's financial condition[177]. Financial Management and Shareholder Value - The company has suspended quarterly dividends on common stock to reinvest in the business, with no expectation of future dividends[157]. - The company has authorized a share repurchase program of up to $50 million, with $20 million already repurchased as of May 31, 2023[165]. - The company may need to raise additional capital, which could dilute existing shareholders and impact stock price[163]. - The company's stock price may be volatile due to various factors, including market conditions and operational performance[160]. - The company’s ability to maintain effective internal controls over financial reporting may be challenged as it grows through acquisitions[156].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended AUGUST 31, 2025 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition period from _________ to _________________ Commission File Number: 000-19954 JEWETT-CAMERON TRADING CO LTD (Name of registrant as specified in its charter) British Columbia, CanadaA1 00-00 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended AUGUST 31, 2025 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition period from _________ to _________________ Commission File Number: 000-19954 JEWETT-CAMERON TRADING CO LTD (Name of registrant as specified in its charter) British Columbia, CanadaA1 00-00 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 1-10596 ESCO Technologies Inc. (Exact name of registrant as specified in its charter) Missouri 43-1554045 (State or other jurisdic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2025 KESTRA MEDICAL TECHNOLOGIES, LTD. (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) 3933 Lake Washington Blvd NE Suite 200 Kirkland, Washington 98033 (Address of Principal Executive Offices) (Zip Code) (Commission File Number) ...

Financial Performance - Record net operating revenues reached $132.4 billion, up 33% from the previous year, with net income increasing 17% to $305.9 million[295][299][302] - Net operating revenues increased by 16% to $2.05 billion, with a diluted earnings per share of $5.89 compared to $5.31 in the previous year[299][302] - Operating revenues increased by $690.7 million, or 20%, to $4,126.9 million for the fiscal year ended September 30, 2025, compared to $3,436.2 million in 2024[305] - Total revenues for the fiscal year ended September 30, 2025, increased to $132,375.0 million, a 32% rise from $99,890.2 million in 2024[350] - Segment income for the fiscal year ended September 30, 2025, was $1,027.7 million, up 16% from $885.6 million in 2024[350] Client Balances and Equity - Average client equity and average money market/FDIC sweep client balances increased by 25% and 21%, respectively, compared to the prior year[296] - Average client equity for listed derivatives increased by 25% to $7,785 million, including an incremental $5.6 billion per month from RJO for two months post-acquisition[310] - Average client equity for listed derivatives rose to $2,114 million, a 23% increase from $1,715 million in 2024[355] - Average client equity for listed derivatives increased by 26% to $5,671 million for the fiscal year ended September 30, 2025[372] Acquisitions - The acquisition of R.J. O'Brien was completed for approximately $651.9 million in cash and stock, significantly enhancing the company's position in the global financial market[290] - The acquisition of Benchmark was completed for approximately $57.1 million in cash, with additional contingent payments valued at $25.3 million[292] - The acquisition of RJO contributed $141.0 million in operating revenues, with listed derivatives revenues increasing by $104.6 million, primarily due to RJO's contribution of $89.5 million[306] - The acquisition of RJO contributed 4.1 million listed derivative contracts in the fiscal year ended September 30, 2025[355] Revenue Sources - Operating revenues from securities transactions rose by $390.9 million, driven by a 27% increase in average daily volume (ADV) and a 9% increase in revenue per million (RPM)[307] - Operating revenues derived from listed derivatives increased by $53.8 million, driven by a 29% increase in contract volumes[357] - Operating revenues from physical contracts increased by $69.1 million, with significant contributions from agricultural and energy sectors[309] - Operating revenues from FX/CFD contracts increased by $59.0 million, driven by a 37% increase in FX/CFD contracts RPM[401] Expenses - Variable expenses accounted for 54% of total expenses, up from 52% in the previous fiscal year[298] - Total fixed compensation and other expenses increased by 14% to $1.04 billion, reflecting growth in acquired businesses and professional fees[302] - Total non-interest expenses for the fiscal year ended September 30, 2025, were $2,243.1 million, up from $1,907.4 million in 2024[337] - Total contractual obligations as of September 30, 2025 amounted to $152,343.7 million, with significant purchase obligations of $149,968.9 million due within one year[470] Interest and Fees - Interest income increased by $337.5 million to $1.7 billion, driven primarily by the acquisition of RJO, which contributed $50 million[296][302] - Total interest expense increased by $297.0 million, or 25%, to $1,480.5 million, driven by growth in the securities repo and lending businesses[314] - Interest expense rose by $259.8 million, or 24%, to $1,332.3 million for the fiscal year ended September 30, 2025, compared to $1,072.5 million in the previous year[372] - Interest and fee income earned on client balances increased by $45.7 million, mainly due to RJO's contribution of $50.0 million[310] Employee and Compensation - The number of employees increased by 874, or 19%, to 5,430 at the end of the fiscal year[323] - Total compensation and other expenses increased by $227.6 million, or 16%, to $1,649.5 million for the fiscal year ended September 30, 2025, compared to $1,421.9 million for the previous year[322] - Variable compensation and benefits rose to $607.1 million, a 20% increase from $506.5 million in 2024, representing 30% of net operating revenues[323] - Fixed compensation and benefits increased by 15% to $500.6 million, up from $435.9 million in 2024[323] Financial Position and Liquidity - Total assets as of September 30, 2025, were $45,268.0 million, compared to $27,466.3 million as of September 30, 2024, reflecting significant growth[445] - As of September 30, 2025, total equity was $2,377.4 million, with outstanding loans under revolving credit facilities and other payables amounting to $782.0 million[437] - The company reported cash, segregated cash, cash equivalents, and segregated cash equivalents increased by $4,847.6 million from $6,672.6 million as of September 30, 2024 to $11,520.2 million as of September 30, 2025[463] - The company had various committed bank credit facilities totaling $1,705.0 million, with $621.8 million outstanding as of September 30, 2025[454] Risk Management and Compliance - The company has implemented credit guidelines to limit current and potential credit exposure to any one counterparty, ensuring risk management in trading activities[479] - Inflation may lead to increased expenses in compensation, transaction-based clearing, and occupancy, potentially affecting the company's financial position and results of operations[481] - The company is in compliance with all financial covenants under its outstanding facilities as of September 30, 2025[456] Taxation - The effective income tax rate was 25% for the fiscal year ended September 30, 2025, down from 26% in 2024[335] - The company repatriated $73.5 million and $100.0 million of earnings previously taxed in the U.S. for the fiscal years ended September 30, 2025, and 2024, respectively[449]

Financial Performance - For the year ended December 31, 2024, the Company reported a net income of approximately $4.2 million, which included approximately $3.6 million of debt forgiveness and $1.2 million of income from investments held in the Trust Account[371]. - For the three months ended June 30, 2025, the Company incurred a net loss of approximately $6.4 million, primarily due to $5.3 million in non-operating losses from changes in fair value of derivative warrant liabilities[374]. - The Company had a net income of approximately $4.5 million for the year ended December 31, 2023, driven by $5.6 million of income from investments held in the Trust Account[372]. Share Redemptions - A total of 28,119,098 Public Shares were redeemed for approximately $287.7 million at a redemption price of about $10.23 per share during the First Extension[350]. - The Second Extension resulted in the redemption of 1,339,804 Public Shares for an aggregate amount of approximately $14.4 million at a redemption price of about $10.74 per share[351]. - During the Third Extension, 2,372,565 Public Shares were redeemed for approximately $26.2 million at a redemption price of about $11.02 per share[352]. - The Fourth Extension saw the redemption of 2,512,919 Public Shares for approximately $28.9 million at a redemption price of about $11.50 per share[354]. Initial Public Offering - The Initial Public Offering generated gross proceeds of $345.0 million from the sale of 34,500,000 Units at $10.00 per Unit, with offering costs of approximately $19.9 million[344]. - As of the Initial Public Offering, 34,500,000 Class A Ordinary Shares subject to possible redemption were presented at redemption value as temporary equity[387]. Business Combination and Extensions - The Company must complete an Initial Business Combination by March 16, 2026, or face liquidation and redemption of Public Shares[360]. - The Company has until March 16, 2026, to consummate the Proposed Business Combination, with substantial doubt raised about its ability to continue as a going concern if not completed[369]. - The Company entered into a Merger Agreement with Innovative Rocket Technologies Inc. on July 22, 2025, which will result in iRocket becoming an indirect wholly-owned subsidiary of Holdco[347]. Financial Position and Liabilities - As of June 30, 2025, the Company had approximately $0 in its operating bank account and a working capital deficit of approximately $2.9 million[362]. - The Company issued a Convertible Note to the Sponsor allowing borrowing of up to $1.5 million for ongoing expenses related to the business and Initial Business Combination[365]. - The Company had borrowings of $450,000 under the Extension Note as of December 31, 2024, which were later forgiven[364]. Trust Account and Deposits - The Company has made monthly deposits of $165,000 and $75,000 into the Trust Account for extensions, totaling $990,000 and $450,000 respectively[350][351]. - The Company made monthly deposits of approximately $80,055.99 to the Trust Account between March 16, 2024, and September 26, 2024, totaling approximately $480,335.94[367]. Regulatory and Compliance - The Company received notice from the NYSE on March 18, 2024, regarding the suspension of its securities listing due to failure to complete an Initial Business Combination within three years of its IPO[361]. - The company is classified as an "emerging growth company" under the JOBS Act, allowing it to take advantage of certain exemptions from reporting requirements[398]. Accounting and Reporting Standards - The company adopted ASU 2023-07 for the annual period ending December 31, 2024, which improves reportable segment disclosure requirements[393]. - The company adopted ASU 2022-03 on December 31, 2023, which clarifies that a contractual sales restriction is not considered in measuring an equity security at fair value[394]. - The company adopted ASU 2016-13 on January 1, 2023, which requires financial assets measured at amortized cost to be presented at the net amount expected to be collected[395]. Administrative and Other Expenses - The Company agreed to pay the Sponsor $10,000 per month for administrative support services starting from the date its securities were listed on the NYSE[380]. - The company received a waiver of underwriter fees amounting to $6,037,500, with $5,579,875 presented in the consolidated statement of changes in shareholders deficit and $457,625 recognized as a gain on the waiver[383]. Shareholder Equity and Warrants - The company recognizes Public Warrants and Private Placement Warrants as derivative liabilities at fair value, with the fair value of Public Warrants as of December 31, 2023, and 2022 based on observable listed prices[386]. - The company calculates net income per ordinary share by dividing net income by the weighted average shares of ordinary shares outstanding for the respective period[389]. - Diluted net income (loss) per share is the same as basic net income (loss) per share for the years ended December 31, 2024, 2023, and 2022, as the exercise of Warrants is contingent upon future events[391]. Off-Balance Sheet Arrangements - As of June 30, 2025, the company did not have any off-balance sheet arrangements[397].

Financial Performance - The company reported a net loss of $21,651,993 for the fiscal year ended August 31, 2025, compared to a net loss of $10,383,171 for the previous fiscal year, indicating a significant increase in losses [29]. - Total liabilities as of August 31, 2025, amounted to $61,462,255, with $32,511,664 related to notes payable for inventory financing [30]. - The company issued 2,986,234 common shares and 1,470,000 pre-funded warrants during the year for net proceeds of $25,103,817, indicating ongoing capital-raising efforts [32]. - The company identified a material weakness in internal controls over financial reporting, which could lead to potential misstatements in financial statements [52]. - The company does not intend to pay dividends for the foreseeable future, focusing instead on capital appreciation for shareholders [118]. - Future equity offerings may lead to substantial dilution of existing shareholders' ownership interests and net tangible book value per share [116]. - The weighted average interest rate on floor plan facilities was 9.7% as of August 31, 2025 [143]. - The balance on all floor plan financings as of August 31, 2025, was $32,511,664 [146]. Market and Economic Conditions - Demand for recreational boats is highly volatile and can be adversely affected by economic downturns, impacting sales and revenues [34]. - Adverse weather conditions during peak boating seasons can materially affect sales and rentals, potentially leading to lower-than-expected annual results [35]. - Rising interest rates could negatively impact consumer financing for boat purchases, affecting overall sales [36]. - Inflationary pressures on raw materials and wages may adversely affect the company's financial results and consumer purchasing behavior [37]. - The company generated the majority of its revenues for the 2025 fiscal year in the United States, exposing it to currency translation and transaction risks due to fluctuations in exchange rates [48]. - The average CAD-USD exchange rate during fiscal 2025 ranged from C$1.4390 to C$1.3546 per $1.00, indicating significant volatility [49]. Operational Risks and Challenges - The acquisition of Nautical Ventures on June 20, 2025, is expected to significantly impact the company's assets and revenues, although integration challenges may arise [33]. - The company relies on key personnel for its operations, and the loss of any of these individuals could adversely affect business performance [38]. - The company is subject to various regulations, and any breaches could have a material adverse effect on its operations and financial results [39]. - The company relies on manufacturers for quality boating products, and any disruptions in their operations could adversely affect inventory availability and business performance [70]. - The company relies on a limited number of suppliers for key components, which may lead to supply chain risks [93]. - The company faces intense competition in a fragmented recreational boat industry, impacting sales and market share [72]. - The company faces risks related to labor and union activities, which could increase employee costs and the risk of work stoppages [105]. - The company relies on network and information systems, and disruptions from cyber threats could materially affect its operations and financial condition [103]. Nautical Ventures Acquisition - The company expanded its business through the acquisition of Nautical Ventures in June 2025, which introduces additional operational risks [64]. - Nautical Ventures' dealership business model is highly leveraged, with significant debt incurred for inventory purchases and property mortgages [67]. - Nautical Ventures accounted for approximately 92.8% of total revenue for the fiscal year 2025, despite only two and a half months of operations within that period [133]. - Revenue from Nautical Ventures primarily derived from the sale of boats from third-party manufacturers, with approximately 89% and 90% of revenues for the year ended December 31, 2024, and the three months ended March 31, 2025, respectively [134]. - Nautical Ventures achieved annual sales near or over $100 million in its past two full calendar years, with boat sales accounting for approximately 80.5% of total revenue in fiscal year 2025 [138]. - Nautical Ventures operates eight locations in Florida, including four dealerships and a marina, contributing significantly to the company's asset base [133]. Electric Powertrain Development - The commercialization of the electric powertrain is uncertain, with no significant customers currently established [88]. - The company plans to upgrade its electric powertrain technology and introduce new models to remain competitive in the electric powerboat industry [97]. - A Manufacture and Supply Agreement with Linamar Corporation was established for the mass production of the E-Motion™ electric powertrain, with a production capacity of 300 powertrains and 150 boats per year at current facilities [98]. - The company did not meet its goal of manufacturing approximately 50 powerboats and beginning commercialization of electric powertrains in 2023, which may require reassessment of business plans [99]. - The company has filed thirteen patent applications related to the E-Motion™ powertrain system and plans to file an additional eleven applications in the next twelve months [107]. - The first fully-electric outboard powertrain system has a maximum power of 180 HP (135 kW), maximum torque of 250 ft.lb (340 Nm), and efficiency of 96% [181]. - The company recorded powertrain efficiencies of more than 96%, significantly higher than the 54% efficiency of the principal competitor's product [148]. - The company generated approximately $57,000 in revenue from the sale of its powertrains in the 2025 fiscal year [149]. - The company announced a strategic partnership with Armada Pontoons to introduce a new electric pontoon boat design [167]. - The E-Motion™ Electric Powertrain System has been approved for inclusion in California's CORE Voucher Incentive Project, allowing for point-of-sale vouchers of up to $170,000 per unit [172]. Future Outlook and Strategy - The company plans to open another rental operation in Dania Beach, Florida, to enhance brand awareness and revenue generation [151]. - Electric boats are expected to see increased sales through Nautical Ventures, leveraging Vision Marine's experience in the electric boating market [141]. - Nautical Ventures aims to sell electric powertrains to OEMs and directly to consumers, identifying a viable market opportunity despite competition [218]. - The company emphasizes its competitive advantages, including proven retail experience and a strong brand reputation [219]. - The company is aware of potential competition from established manufacturers like Torqeedo and the risk of OEMs producing their own powertrains [218]. - The company focuses on strategic high visibility geographic positioning for its dealerships and operations [219].